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Abstract  24 
Background: Exercise is beneficial in pulmonary arterial hypertension (PAH), although studies to date 25 
indicate little effect on the elevated pulmonary pressures or maladaptive RV hypertrophy associated with 26 
the disease.  For chronic LV failure, high intensity interval training (HIIT) promotes greater endothelial 27 
stimulation and superior benefit than customary continuous exercise training (CExT); however, HIIT has 28 
not been tested for PAH. Therefore, here we investigated acute and chronic responses to HIIT vs. CExT 29 
in a rat model of monocrotaline- (MCT) induced mild PAH. Methods: Six weeks of treadmill training 30 
(5x/week) was performed, as either 30 min HIIT or 60 min low-intensity CExT. To characterize acute 31 
hemodynamic responses to the two approaches, novel recordings of simultaneous pulmonary and 32 
systemic pressures during running were obtained at pre- and 2, 4, 6, and 8 weeks post-MCT utilizing 33 
long-term implantable telemetry. Results: MCT-induced decrement in VO2max was ameliorated by both 34 
HIIT and CExT, with less pronounced pulmonary vascular remodeling and no increase in RV 35 
inflammation or apoptosis observed. Most importantly, only HIIT lowered RV systolic pressure, RV 36 
hypertrophy, and total pulmonary resistance, and prompted higher cardiac index; complemented by a RV 37 
increase in the positive inotrope apelin and reduced fibrosis. HIIT prompted a markedly pulsatile 38 
pulmonary pressure during running and was associated with greater lung endothelial nitric oxide synthase 39 
after 6 weeks. Conclusion: HIIT may be superior to CExT for improving hemodynamics and maladaptive 40 
RV hypertrophy in PAH. HIIT’s superior outcomes may be explained by more favorable pulmonary 41 
vascular endothelial adaptation to the pulsatile HIIT stimulus. 42 
 43 
Introduction 44 
Pulmonary arterial hypertension (PAH) causes progressive remodeling of small to midsize pulmonary 45 
arteries that is dominated by medial hypertrophy and vasoconstriction, and that leads to right ventricular 46 
(RV) failure and death (3). Despite the development of several new drug therapies for PAH which have 47 
improved overall survival rate (31), most patients continue to exhibit significantly reduced exercise 48 
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tolerance(4, 53) and quality of life. Until recently, practitioners generally discouraged aerobic exercise for 49 
patients with PAH. Over the past few years, this opinion has shifted toward a more liberal 50 
recommendation in favor of exercise, including a grade 1A recommendation at the 5th WHO World 51 
Symposium on PH (19). However, this recommendation has been made in the absence of clinical or 52 
preclinical evidence about the duration or intensity of exercise. Moreover, there is lack of evidence of 53 
salutary effects of exercise training on cardiopulmonary hemodynamics or RV function (13, 17, 23, 40, 54 
43, 48, 62) that would suggest that there are adaptations to the afterload increase in PAH.   55 
Individualized exercise prescription is essential, where exercise parameters are set based on objective 56 
evaluation of patient exercise response (42), but optimal mode of delivery for a prescribed exercise 57 
workload in PAH has not been investigated.  The exercise prescription with the highest therapeutic index 58 
for PAH may require an approach alternative to the customary continuous exercise training (CExT) 59 
protocol utilized in most cardiopulmonary rehabilitation settings and patient-directed independent 60 
programs. Multiple studies indicate greater favorable cardiovascular adaptations after exercise performed 61 
at higher intensity than at low or moderate levels for healthy humans(26, 45), and for animal models and 62 
humans with coronary artery disease (50), myocardial infarction and left ventricular (LV) dysfunction 63 
(14, 25), and chronic obstructive pulmonary disease(15, 47).  High intensity interval training (HIIT), 64 
alternating intervals of high intensity and low intensity exercise, is superior to CExT in chronic LV failure 65 
(2), with evidence even for reversal of LV remodeling in patients following an intervention of HIIT but 66 
not of CExT (61).  However, the opposite was recently reported in a pre-heart failure hypertension rat 67 
model where 4 weeks of HIIT promoted significant pathological LV adaptation not observed for CExT 68 
trained and untrained animals (30). Such contradictory findings highlight the importance of studying 69 
disease-specific responses to HIIT, or any exercise approach, prior to establishing as clinical practice. 70 
Therefore, the purpose of this study was to compare outcomes and training adaptations of the lungs, RV 71 
and soleus muscle in a rat model of PAH following a 6 week protocol of HIIT vs. CExT. Moreover, to 72 
ascertain dynamic changes in hemodynamic responses during the two types of exercise, a rat was 73 
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instrumented with implantable telemetric probes. We hypothesized that since higher exercise pressures 74 
prompt greater flow-mediated endothelial shear stress (6), HIIT would provide greater pulmonary 75 
vascular endothelial stimulation and more robust training-induced nitric oxide (NO) pathway 76 
enhancement for improved hemodynamics, attenuated RV maladaptive remodeling, and better exercise 77 
capacity.  78 
Methods  79 
PAH induction and experimental groups. The experimental protocol was approved by the Institutional 80 
Animal Care and Use Committee of Indiana University, which is in compliance with National Institutes 81 
for Health guidelines. All animals received care in compliance with the Guide for the Care and Use of 82 
Laboratory Animals. PAH was induced in male Sprague-Dawley rats (~300g, Charles River and Harlan) 83 
by administration of 40 mg/kg monocrotaline (MCT, Sigma Aldrich) subcutaneously (s.q.), which 84 
reliably induces stable mild PAH after 2 weeks(54). We employed a mild PAH phenotype to reflect 85 
patients in early or controlled disease stages who may be better suited to the intensity of high intervals 86 
utilized in traditional HIIT (~90%VO2R), as we have tested here(25, 60).   87 
Control (CON) animals received s.q. vehicle (saline). Animals were assigned to one of six groups: 1) 88 
MCT plus a 6 wk protocol of continuous exercise training (MCT-CExT; n=7), 2) MCT plus a 6 wk 89 
protocol of HIIT (MCT-HIIT; n=8), 3) MCT but ‘sedentary’ with no training program (MCT-SED; 90 
n=10), 4) Saline control plus continuous exercise training (CON-CExT; n=5), 5) Saline control plus HIIT 91 
(CON-HIIT; n=6), 6) Saline control sedentary (CON-SED; n=6).  92 
VO2max testing. As running on treadmill is a skilled activity for rats, all rats were familiarized to the 93 
treadmill (Columbus Instruments, Columbus, OH) at speeds and inclines that would be required during 94 
subsequent testing, as previously performed by our group(9, 38). Figure 1 presents a schematic of the 95 
protocol timeline. Immediately prior to MCT/saline injections, exercise testing was performed for all 96 
animals to determine maximal aerobic capacity (VO2max; expressed relative to body weight) using 97 
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indirect open-circuit calorimetry (Oxymax, Columbus Instruments, Columbus, OH) and an incremental 98 
treadmill protocol in 3 min stages (8, 59). Exercise testing was repeated for all rats at two and eight weeks 99 
post-injection.  100 
Treadmill training. A 6 week treadmill running program was initiated for rats assigned to exercise 101 
training, performed in 5 sessions/week. For rats assigned to CExT, uninterrupted steady state running was 102 
performed with treadmill speed and incline set to elicit an intensity of 50% of VO2 Reserve (VO2R) 103 
determined in the second exercise test, calculated for each animal by the method of Karvonen as 104 
[(VO2max – VO2resting) x 0.50] + VO2resting.  The intensity of 50%VO2R was chosen as it is within the 105 
exercise intensity range recommended by the American College of Sports Medicine for exercise 106 
prescription in cardiopulmonary patients(42). Session duration was progressed from 30 min up to 60 min 107 
by the end of week 2.  108 
For rats assigned to HIIT, sessions began with a 6 min warm up at 50% VO2R then proceeded into five 5 109 
min cycles of alternating high and low intensity intervals: 2 min at 85-90% VO2R and 3 min at 30% 110 
VO2R (totaling 30 min).  Training time between HIIT and CExT were intentionally unmatched as it is an 111 
important aspect of the HIIT approach that only ~half of the session duration of CExT is required to 112 
achieve similar work performed.  Rats assigned to remain sedentary (SED) were placed on a stationary 113 
treadmill on a matched schedule. 114 
Invasive hemodynamic measurements.  Three days following the final exercise test, rats underwent non-115 
survival surgery for invasive hemodynamic measurements. We waited for three days in order to avoid 116 
confounding effects of the exercise tests(9, 38). Rats were anesthetized by inhaled inhaled isofluorane, 117 
orotracheally intubated, and mechanically ventilated (rate of 68 breaths/min, volume is adjusted as 118 
necessary to keep arterial blood gases within normal parameters). Isofluorane delivery was set to 5% for 119 
induction and 2% for maintenance, with a gas mixture initially at 100% oxygen then stabilized at room 120 
air. The left carotid artery was cannulated with PE-50 tubing and the right internal jugular vein was 121 
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cannulated with a 2F Millar catheter (Millar Instruments, Houston, TX) for recordings of pulmonary and 122 
systemic pressures as described previously (37), with correct RV catheter position determined by wave 123 
form analysis indicating typical RV waveform. RV systolic pressure (RVSP) and mean arterial pressure 124 
(MAP) were assessed at room air during normocapnia and normal pH (determined via i-STAT blood gas 125 
analyzer [Abbott Point of Care Inc., Princeton, NJ]).  126 
Implantable telemetry. In order to assess dynamic changes in RV and systemic pressure during exercise, a 127 
male Sprague-Dawley rat (280g) was instrumented with an implantable telemetry sensor-transmitting 128 
probe (model HD-S21 Data Sciences International, DSI, Minneapolis) via laparotomy and thoracotomy as 129 
previously described (9).  Following surgery, the animal recovered for two weeks prior to exercise testing 130 
and MCT administration (40 mg/kg).  To assess hemodynamic response to treadmill running loads 131 
required by CExT and HIIT protocols, serial exercise testing was performed for the instrumented rat over 132 
an 8 week period (pre-MCT, and at 2 week intervals post MCT). The testing was conducted over three 133 
consecutive days and consisted of:  1) Determination of VO2max as described above; 2) 30 min sampling 134 
of steady state running at 50%VO2R, identical to that utilized for training of the CExT rats; and 3) 30 min 135 
sampling of alternating high (85-90%VO2R) and low (30%VO2R) intensity running, identical to that 136 
utilized for training of the HIIT rats. Recordings of systemic blood pressure (abdominal aorta), RV 137 
pressures, heart rate (HR), EKG (electrodes over the right pectoral muscle and left caudal rib region), and 138 
body temperature were obtained at rest and during all treadmill testing, as well as during recovery from 139 
testing.  140 
Echocardiography. A recent report of HIIT promoting pathological LV adaptation for pre-heart failure 141 
hypertension rats(30) prompted us to include echocardiography to rule out potential worsening of RV 142 
function for HIIT-trained MCT rats. Echocardiography was performed before and after the 6 weeks of 143 
HIIT and compared to parameters obtained for a subset of untrained (SED) MCT and CON animals. Rats 144 
were lightly anesthetized with 1-2% isoflurane via nose cone and images were obtained by a blinded 145 
sonographer as previously described by our group(18). Upon determination of all echocardiographic 146 
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endpoints, rats were recovered from anesthesia. Wall thicknesses, pressures and other derived values were 147 
assessed in accordance with published methods(39) including cardiac output (derived from RV outflow 148 
tract diameter and velocity time integral), which is expressed relative to body mass as cardiac index. 149 
Index of total pulmonary vascular resistance (TPRi) was calculated as reported, which divides the RVSP 150 
by the cardiac index.  151 
Tissue harvest. On the final day of the protocol, immediately following the invasive hemodynamic 152 
measurements, rats were sacrificed under anesthesia via exsanguination and lungs, heart, and soleus were 153 
harvested as reported previously by our group(37). For consistency, tissues from the telemetry-implanted 154 
rat were not included in the morphometry and biochemical assays.   155 
Pulmonary vascular remodeling. Lungs were flushed with normal saline through a catheter in the 156 
pulmonary artery (PA) until clear return was obtained from the left atrium. After excision of the right 157 
lung, the left lung was then inflated with formalin/agarose via the trachea with 10% buffered formalin in 158 
agarose under constant pressure (15 mmHg), removed from the thoracic cavity, and paraffin-embedded. 159 
To characterize the pulmonary vascular phenotype in terms of pulmonary arterial wall hypertrophy, 160 
Verhoeff-Van Giesson (VVG) immunohistochemical staining was performed on lung sections of the three 161 
MCT groups and the untreated control (CON-SED) animals. Pulmonary vascular wall area was then 162 
determined from brightfield microscopy images in a blinded fashion for small and medium-sized PAs 163 
(<200 µm diameter, 10 vessels per animal, 20x objective) as previously described by our group(18).  164 
Assessment of lung eNOS. To investigate training impact on a key regulator of pulmonary vascular tone, 165 
endothelial nitric oxide synthase (eNOS) expression and activation status was assessed in lung tissues 166 
from the three MCT groups and the untreated control animals. Measurement of lung total eNOS and 167 
eNOS phosphorylated at activating site Serine 1177 or at inhibiting site Threonine 495 sites (p-168 
eNOSSer1177 and p-eNOSThr495, respectively) was performed via electrophoresis and immunoblot analysis 169 
of lung homogenates as previously described by our group(9). Primary antibodies were a polyclonal 170 
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antibody for eNOS (Santa Cruz Biotechnology, 1:200 dilution), p-eNOSSer1177 (Cell Signaling, Danvers, 171 
MA, 1:500 dilution), p-eNOSThr495 (Cell Signaling, 1:500 dilution), or vinculin (Sigma Aldrich, 1:1000 172 
dilution) as loading control. The intensity of Western blotting bands was measured by densitometry using 173 
ImageJ software (NIH; Baltimore) and expressed normalized to vinculin band intensity and relative to 174 
untreated controls. 175 
Right ventricular hypertrophy. RV hypertrophy was assessed by measuring the widely used Fulton index 176 
(weight of RV divided by weight of the left ventricle plus septum; RV/[LV+S]) as described previously 177 
(37) with a value >~0.30 expected in the PH rat model.  Immediately after determination of RV and 178 
LV+S weights, sections of the RV were snap-frozen for further biochemical analyses or immersed in 10% 179 
buffered formalin for immunohistochemistry  studies. An additional assessment of RV hypertrophy was 180 
provided by echocardiographic measurement of RV wall thickness and change from baseline in RV wall 181 
thickness by blinded sonographer.  182 
RV apelin. Since apelin is recognized as a potent inotropic, anti-apoptotic and anti-inflammatory mediator 183 
that has been reported to be down-regulated in the RV of MCT rats (16), RV apelin levels were assessed 184 
via electrophoresis and immunoblot analysis of RV homogenates of the three MCT groups and the 185 
untreated control animals. Equal amounts of protein (determine by bicinchoninic acid protein assay) were 186 
resolved by 7.5% SDS-PAGE, followed by immunoblotting with rabbit polyclonal antibody (1:500, 187 
Abcam), followed by secondary anti –rabbit antibody (1:2000, Abcam). The intensity of Western blotting 188 
bands was measured by densitometry using ImageJ software (NIH; Baltimore) and expressed normalized 189 
to vinculin band intensity and relative to sedentary MCT animals.  190 
RV and skeletal muscle metabolism. To further characterize the MCT phenotype, and to investigate 191 
potential training induced adaptations in myocardial or skeletal muscle substrate utilization, indicators of 192 
oxidative and non-oxidative (glycolytic) metabolism were assessed in RV and soleus samples of the three 193 
MCT groups and the untreated control animals. For western blotting of RV and soleus whole-muscle 194 
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homogenates, equal amounts of protein (determined by bicinchoninic acid protein assay) were resolved 195 
by 7.5% SDS-PAGE, followed by immunoblotting using a total oxidative phosphorylation antibody 196 
cocktail (OXPHOS; Abcam, diluted 1:500) and using rat heart mitochondria (Abcam) as a positive 197 
control. The intensity of Western blotting bands was measured by densitometry using ImageJ software 198 
(NIH; Baltimore) and expressed normalized to vinculin band intensity and relative to sedentary MCT 199 
animals. Oxidative capacity of the RV and soleus was also evaluated by assessment of glucose 200 
transporter-1 (GLUT-1) abundance as an indicator of cytoplasmic glycolysis. Immunofluorescent staining 201 
for Glut-1 (Abcam #ab652; Cambridge, MA, at 1:150 dilution) was performed on cryofixed RV and 202 
soleus as previously described by our group(9). Mean pixel intensity of GLUT-1 staining was determined 203 
using ImageJ software (NIH; Baltimore) and expressed relative to sedentary MCT animals.    204 
RV inflammation, fibrosis, and apoptosis. To assess whether the high work rates encountered during 205 
intense intervals of a HIIT session may induce detrimental RV responses with chronic use, RV 206 
inflammation, apoptosis, and fibrosis were examined for the three MCT groups and the untreated control 207 
animals using immunofluorescence and histological assays. Lymphocyte infiltration was assessed as an 208 
indicator of RV inflammation via immunofluorescence staining for CD45 (Santa Cruz Biotechnology, 209 
Dallas, TX, 1:20 dilution) in RV cryosections as previously described by our group(9). CD45+ counts 210 
were expressed as the number of positive stained cells per field, averaging at least six randomly chosen 211 
fields per RV. Cardiomyocyte apoptosis was assessed with terminal deoxynucleotidyl transferase dUTP 212 
nick end labeling (TUNEL) of RV cryosections according to the manufacturer’s instructions (Roche 213 
Applied Science, Indianapolis, IN) with DAPI co-staining and expressed relative to nuclei count. RV 214 
fibrosis was assessed on formalin-fixed paraffin-embedded RV sections as % positively stained area with 215 
Masson’s trichrome staining and expressed relative to MCT sedentary animals.  216 
Statistical analyses. Data are presented in figure graphs as means ± standard error (mean±SEM).  An 217 
analysis of variance (ANOVA) by group assignment was performed with repeated measures (exercise 218 
testing and body mass data at three time points) or without repeated measures (hemodynamic data and 219 
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Fulton index) as appropriate; using Tukey’s multiple comparison post-test analysis to determine between-220 
group differences. ANOVA was also implemented for data from histological and biochemical assays 221 
performed for the three MCT groups and the untreated healthy control group (CON-SED). 222 
Echocardiographic data obtained at two time points (pre- and post-training) for HIIT and SED animals 223 
(both MCT and CON) were evaluated using repeated measures ANOVA. Pearson product correlations 224 
were performed to further explore relationships between dependent variables.  All statistical analysis was 225 
carried out using SPSS, version 23.0, and differences at α level of 0.05 (p<0.05) were considered 226 
statistically significant.  227 
Results  228 
CExT and HIIT improve aerobic exercise capacity in mild PH 229 
Aerobic capacity. Two weeks after MCT, rats showed a mild PH phenotype, evidenced by a reduction 230 
from baseline in aerobic capacity (by -7±1.5%,  Fig 2A), and faster time to exhaustion (Fig 2B). In 231 
contrast, there was no change (p>0.05) from baseline for saline-injected animals. Together, these data 232 
suggest an expected impairment in physical function in MCT injected rats prior to intervention and this 233 
impairment was similar (p>0.05) between rats assigned to HIIT vs. CExT groups. Since training 234 
workloads were set relative to each rat’s individually-determined post-injection maximum, the group 235 
means (±SEM) for treadmill speed (m/min) and incline (deg) eliciting a relative training intensity of 236 
50%VO2R used in CExT was lower as expected for MCT-CExT (9.3±0.6, 2.9±1) compared to CON-237 
CExT (12±1.3, 7±1.2). Likewise, mean (±SEM) treadmill speed utilized for the high intensity intervals of 238 
HIIT performed at an incline of 25° to elicit 85-90%VO2R was lower for MCT-HIIT (14.2±0.3 inc 25) 239 
compared to CON-HIIT (16.3±0.2).  240 
Importantly, MCT rats treated with either HIIT (p<0.01 vs. MCT-SED) or CExT (p<0.05 vs. MCT-SED) 241 
exhibited more preserved VO2max and time to VO2max, with pre- to post-training change (Fig 2A,B) not 242 
different (p>0.05) from that for CON-SED over the same time period. While the total number of training 243 
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minutes for HIIT was half as much as for CExT, calculated cumulative work performed for MCT rats 244 
over the 6 weeks was comparable between HIIT and CExT groups as intended (4573±218, 3745±616 245 
joules, p=0.4). Change in body mass over the study period (Fig 2C) was not differently affected by group 246 
assignment (p>0.05).  247 
HIIT is associated with lower RV pressures 248 
At 8 weeks post-MCT, unexercised (MCT-SED) rats exhibited resting RVSP values (Fig 3A) that were 249 
~60% greater compared to CON rats. MCT-HIIT rats, on the other hand, exhibited RVSP values that 250 
were similar to CON, and significantly lower than both MCT-CExT and MCT-SED. However, 251 
continuous exercise had no salutary effect on RVSP as MCT-CExT exhibited RVSP values that were 252 
similar to MCT-SED, and significantly higher than both MCT-HIIT and CON rats. Aortic blood pressures 253 
(BP) were similar (p>0.05) among groups, with mean arterial pressure values of 92±4.4, 100±8.7, 99±6.7, 254 
105±7.3, 113±7.0, and 97±5.5 mmHg for MCT-CExT, MCT-HIIT, MCT-SED, CON-CExT, CON-HIIT, 255 
and CON-SED, respectively.   256 
Larger post-exercise reduction in RVSP with HIIT  257 
Figures 3B-D show hemodynamics in the chronically instrumented rat, at rest (B), and responses to 258 
exercise (C, D). RVSP at rest is increased by MCT injection in this animal by ~60% by week 4 with 259 
unchanged systemic pressures (Fig 3B). Most importantly, exercise data reveal that, in contrast to the 260 
steadier hemodynamics observed during CExT running (right panel, Fig 3C), pronounced ‘surges’ in 261 
RVSP occurred during HIIT running which corresponded to the high intensity run intervals (left panel, 262 
Fig 3C). Further, hemodynamic recordings collected during recovery from these run bouts (striped bars, 263 
Fig 3D) reveal a more marked post-exercise reduction in RVSP from resting values following a HIIT 264 
session compared to a CExT session, suggesting heightened provocation of acute vasodilation by HIIT.  265 
Larger post-exercise reduction in RVSP with HIIT is associated with increased lung eNOS expression 266 
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Since the telemetry studies suggested a more pronounced vasodilation effect after HIIT, we measured 267 
eNOS expression in lung homogenates of HIIT-, CExT-, and SED- MCT rats and untreated healthy 268 
controls (CON-SED). Interestingly, MCT-HIIT exhibited greater fold increase in total eNOS protein than 269 
MCT-SED (p<0.05) and CON-SED (p<0.01) (Fig 4A). Phosphorylation of eNOS at activation (serine) 270 
and inhibitory (threonine) sites was not different with training (data not shown). Taken together, the 271 
telemetric exercise pressure recordings and biochemistry data indicate that HIIT running prompts an acute 272 
pulmonary hemodynamic response distinct from CExT running, and is associated with higher lung eNOS 273 
abundance and lower resting RVSP in MCT-PH.   274 
Preserved pulmonary vascular structure in exercised MCT rats   275 
Pulmonary arterial wall thickness (by VVG staining, Fig 4B) was greater for MCT animals in both small 276 
diameter (<100 µm, left panel) vessels, by 30% (MCT-CExT and HIIT) to 45% (MCT-SED), and 277 
medium diameter (100 to 200 µm, right panel) vessels, by 26% (MCT-CExT and HIIT) to 50% (MCT-278 
SED). While there was no significant difference in MCT rats between trained vs. sedentary animals, no 279 
significant increase in pulmonary arterial wall thickness was observed for the trained animals (both HIIT 280 
and CExT), whereas MCT-SED was significantly increased when compared to healthy controls 281 
(p<0.01for small diameter vessels, p<0.05 for medium diameter vessels, vs. CON-SED). This suggests 282 
potential beneficial effects of exercise training on pulmonary artery remodeling. 283 
Less RV hypertrophy and better RV function with HIIT 284 
MCT animals treated with HIIT had ratio of RV to LV+S mass (Fig 5A) similar to that of healthy (CON-285 
CExT, -HIIT, -SED) animals; this observation was absent in MCT animals treated with CExT. Given the 286 
beneficial effects of HIIT on cardiopulmonary hemodynamics and RV hypertrophy, we performed 287 
echocardiography to further characterize RV function in these animals. We confirmed the findings 288 
suggested by the Fulton index by demonstrating that HIIT-trained MCT animals exhibited an attenuated 289 
increase in RV free wall thickness over 6 weeks (Fig 5B, upper panel) compared to sedentary MCT 290 
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(p<0.05), resulting in lower final wall thickness compared to sedentary MCT (p<0.05). Further, 291 
echocardiography indicated improvement in RV function in HIIT trained MCT, including better-292 
maintained cardiac output over 6 weeks (cardiac index Fig 5C, upper panel), p<0.05), lower final index 293 
of total pulmonary vascular resistance (TPRi, Fig 5D, upper panel), and tendency for better ratio of 294 
pulmonary artery acceleration time over pulmonary artery ejection time (PAAT/PET, p=0.07) vs. MCT-295 
SED. Correlation analysis indicated that final RVSP was related to RV hypertrophy as determined by 296 
Fulton index (R= 0.64, p<0.01) as well as by wall thickness in echocardiography (R= 0.65, p<0.01). A 297 
differential effect of HIIT on echocardiographic parameters was not observed for CON animals (lower 298 
panels, Fig 5B-D) except in cardiac output and cardiac index where SED animals exhibited increase over 299 
6 weeks, contrary to that observed in MCT-SED.  300 
Training impact on RV and skeletal muscle metabolism  301 
Untreated MCT rats (MCT-SED) exhibited greater abundance of Glut-1 in immunofluorescence staining 302 
of RV (Fig 6A) and soleus (Fig 6B) compared to untreated healthy controls (CON-SED), suggesting a 303 
shift toward glycolytic (non-oxidative) metabolism in both cardiac and skeletal muscle. Interestingly, both 304 
HIIT- and CExT- trained MCT rats exhibited less Glut-1 (p<0.01) compared to MCT-SED in the RV (Fig 305 
6A). However, only HIIT was associated with increased RV expression of an electron transport chain 306 
complex, cytochrome IV (Fig 6C). Training effects were also observed for soleus, but in contrast to those 307 
observed in the RV, occurred only with a CExT approach. Only MCT-CExT exhibited similar soleus 308 
Glut-1 (Fig 6C) to CON-SED, with a tendency (p=0.08) for increased soleus expression of an electron 309 
transport chain complex, cytochrome III, vs. MCT-HIIT and MCT-SED (Fig 6D). Taken together, these 310 
data indicate that exercise training- in either a HIIT or CExT regimen- may positively impact MCT-311 
induced glycolytic shift in RV and skeletal muscle.  312 
RV inflammation, fibrosis, and apoptosis 313 
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To investigate potential adverse effects of training, biochemical assays were performed to evaluate RV 314 
fibrosis, inflammation and apoptosis for all trained and sedentary MCT rats and untreated healthy control 315 
rats (CON-SED). Immunoblotting experiments revealed a training effect on RV apelin, an anti-apoptotic 316 
and anti-inflammatory mediator and positive inotropic regulator that is inducible by exercise. Much 317 
higher RV apelin was observed with HIIT vs. CExT (increased by ~75%, p<0.01) (Fig 7A). Neither HIIT 318 
nor CExT increased RV inflammatory or apoptotic cells as indicated by similar levels (p>0.05 vs. MCT-319 
SED) of CD45+ (Fig 7B) and TUNEL+ cells (Fig 7C).  Interestingly, MCT-induced increase in RV 320 
fibrosis (trichrome staining, Fig 7D) was attenuated by HIIT (by approximately one-third, p<0.05 vs. 321 
MCT-SED) which supports echo data of improved RV function in these animals.  322 
Discussion 323 
Our most important finding was that while both HIIT and CExT attenuated MCT-induced decrement in 324 
aerobic capacity, only HIIT lowered pulmonary pressures and attenuated RV hypertrophy and 325 
dysfunction. Previous studies of chronic exercise effects in animals and in patients with PAH revealed 326 
mixed impact on hemodynamics, with one study demonstrating a small but statistically significant 327 
training-induced lowering of resting pulmonary pressures (23), but all other studies indicating no effect 328 
(17, 22, 24, 43). To our knowledge, this is the first exercise intervention associated with robust favorable 329 
impact on hemodynamics and the RV in PAH.  330 
Our data show for the first time that chronic exercise-induced upregulation of endogenous pulmonary 331 
eNOS expression in PAH, which has previously been demonstrated in healthy animals and models of 332 
systemic vascular disease(34, 36, 52, 65). While immunoblotting data may not necessarily reflect nitric 333 
oxide (NO) bioavailability, increased eNOS increases NO production(44)  and NO-dependent arterial 334 
relaxation(21, 33, 36), both typically impaired in PAH (35). We found an increase in total eNOS protein 335 
with HIIT, but no change in phosphorylation pattern. This was not surprising since final exercise bout and 336 
tissue harvest were separated by three days to mitigate confounding effects of acute exercise on chronic 337 
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adaptation. In our previous work, a single bout of moderate intensity exercise (75% VO2max) induced 338 
acute pulmonary eNOS activation (as determined in serine and threonine phosphorylation) in lung tissue 339 
collected an hour later and transiently normalized pulmonary pressure in a MCT (50 mg/kg) rat model of 340 
moderate PAH (9). In that work, telemetric recordings during running also indicated a running-induced 341 
acute pulmonary pressure reduction, as we have seen here (Fig 3D, striped bars), and concomitancy with 342 
unchanged stroke volume (estimated by O2 pulse [VO2 per heart beat]) supported a mechanism of acute 343 
pulmonary resistance reduction (e.g. vasodilation) and not an acutely failing RV.  We believe this also to 344 
be the case for the present telemetric observations of post-running pulmonary pressure reduction (Fig 3D, 345 
striped bars). However, since assumptions about the relationship between oxygen consumption and heart 346 
rate are not upheld during non-steady state running (precluding calculation of O2 pulse), it is not possible 347 
to ascertain relative contribution of acute changes in pulmonary resistance vs. RV contractility underlying 348 
the more pronounced acute pulmonary pressure relief evoked by HIIT (black striped bars).  349 
The augmented exercise-induced pulmonary eNOS activation and enhanced acute post-exercise 350 
pulmonary vasodilatory response in MCT-PAH rats (9) may be a consequence of higher flow-mediated 351 
shear forces. With chronic exercise, only applied as HIIT resulted in greater total pulmonary eNOS 352 
protein, and alleviated pulmonary hypertension (Fig 3 and 4) while mild intensity continuous exercise 353 
stimulus (50% VO2max, CExT) did not. The induction of eNOS protein and improved pulmonary 354 
pressures following HIIT but not CExT may be explained by a difference in the pulmonary vascular 355 
stimulation provided by the two training approaches. Telemetric recordings during HIIT and CExT 356 
sessions revealed very different exercise hemodynamic profiles generated by the two approaches where 357 
HIIT running was accompanied by quick-changing, high magnitude pulmonary pressures (Fig 3C, left 358 
panel) in contrast to an elevated but relatively unchanging pulmonary pressure in CExT running (Fig 3C, 359 
right panel). The ability for shear forces at the vessel wall to prompt bursts of NO production acutely and, 360 
when applied repeatedly, to enhance NO signaling machinery is enhanced in the presence of quick-361 
changing, high magnitude shear as opposed to statically-applied shear (6).  This is in agreement with 362 
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multiple studies demonstrating superior improvement in vascular function as assessed via brachial artery 363 
flow-mediated dilation with a HIIT approach compared to traditional continuous training (27, 58). 364 
Abnormal microvascular shear adaptation has been reported for a rat model of PAH induced by vascular 365 
endothelial growth factor receptor blocker Sugen5416 +hypoxia (57), as well as in patients (57), 366 
promoting lung endothelial injury and vessel remodeling (57). Therefore, future work should directly 367 
investigate if the quick-changing, high magnitude pulmonary pressures we observed during HIIT helps to 368 
restore microvascular shear responses in PAH and how this relates to disease progression.  369 
Improved pulmonary hemodynamics in HIIT trained MCT may explain the pronounced reduction in 370 
resting RVSP measures (Fig 3A) and RV hypertrophy (Fig 5A,B), which we interpret as evidence of 371 
benefit. Serial echocardiographic measures revealed lower pulmonary resistance and higher cardiac 372 
output (TPRi and cardiac index, Fig. 5C,D) for HIIT trained animals. Superior outcomes with HIIT may 373 
have also been derived from direct effects on the RV. Histological and biochemical assessment of the RV 374 
indicated a healthier myocardium for HIIT-trained MCT including greater apelin expression (Fig 7A), 375 
less fibrosis (Fig 7D), and potentially less metabolic dependence on cytoplasmic glycolysis (Fig 6A,B).  376 
Apelin has been recognized as a potent inotropic substance and strong vasodilator, hence its increased 377 
interest as a potential treatment/biomarker of PAH(1), and its response to treatment, including 378 
exercise(63). We previously identified apelin to be an important contributor to RV function in our lab, 379 
which prompted us to include RV apelin expression as a secondary endpoint. To our knowledge, ours is 380 
the first report of training induced changes in RV apelin.  The higher RV apelin observed for MCT rats 381 
following 6 weeks of HIIT may have contributed to the improved RV function observed in these animals 382 
via direct effects on myocardial contractility. 383 
Our observations regarding training impact on indicators of glycolytic vs. oxidative metabolism are 384 
particularly relevant in light of the growing evidence that PAH is associated with an inefficient metabolic 385 
shift(56) in both cardiac and skeletal muscle mitochondrial substrate utilization from aerobic to anaerobic 386 
metabolism that contributes to diminished exercise tolerance(41, 49). Direct measures of myocyte 387 
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metabolism were beyond the scope of this work; however, immunostaining and immunoblotting data (Fig 388 
6A,B), indicate an interesting possible differential response of skeletal and cardiac muscle to training 389 
approach. More robust oxidative metabolic adaptations were observed in the RV myocardium in response 390 
to HIIT, while training induced metabolic adaptations in the soleus were only observed for the CExT 391 
approach.  This is in agreement with other studies that have reported divergent adaptive responses by 392 
muscle types, for example, in a Dahl sodium sensitive rat model of hypertension, not only did CExT 393 
prompt greater oxidative metabolic adaptations compared to HIIT in skeletal muscle, findings in white vs. 394 
red gastrocnemius indicated a fiber type-specificity to this response (29).   The absence of a robust 395 
skeletal muscle metabolic training adaptation in our HIIT rats may be a consequence of the lower absolute 396 
workloads and session duration of our protocol compared to that in other studies(46, 64) utilizing more 397 
physically-able disease models, and workloads set relative to calculated critical power(11), and thus may 398 
not have provided a sufficient stimulus to achieve these effects.   399 
Exercise may worsen RV inflammation in PAH if coincident with excessive RV wall stress (28),  as 400 
reported with high left ventricular (LV) wall stress in an LV overload rodent model (55), and systemic 401 
hypertension rodent models(12, 51). Despite the high work-rate run intervals,  HIIT treated rats had no 402 
evidence of heightened RV pro-inflammatory/apoptotic signaling for MCT, nor was this observed for 403 
CExT trained MCT (Fig 7 A-D), which is in contrast to that reported after 6 weeks of treadmill (CExT-404 
type) training for rats that received 60 mg/kg MCT (28). The reasons we did not observe increased 405 
inflammation may result from a less severe model of PAH, and because we adjusted the treadmill 406 
workload relative to each animal’s post-disease VO2max, in order to avoid greater relative strain on 407 
animals with worse disease, and more closely reflect individualized exercise prescription for patients.  408 
Limitations and future directions. First, the relationship between higher exercise pressures of HIIT and 409 
the positive adaptations we observed (enhancement of hemodynamics and exercise capacity, attenuation 410 
of RV maladaptive remodeling), is indirect and remains associative until future mechanistic experiments 411 
directly interrogate causation of these adaptations by HIIT’s higher exercise pressures. Second, we tested 412 
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the effect of exercise on male rats with a mild PH phenotype. While this may suggest the translation of 413 
our findings to clinical exercise interventions may be focused on early disease, it remains to be 414 
determined if prescribed training applications as we have tested here will have similar benefit with no 415 
detrimental RV effects in more angioproliferative severe PH, as well as in females. Given the known 416 
sexual dimorphism in PAH incidence(5), outcomes(31, 32), and acute exercise responses(38), sex 417 
differences in the training adaptations we have described here remain to be investigated. Lastly, the 418 
exercise sessions of the HIIT and CExT groups were performed with identical session frequency but were 419 
not time matched, with CExT sessions lasting 60 min but HIIT sessions only half of that duration.  While 420 
this more accurately reflects how HIIT is performed in clinical practice, it introduces the possibility that 421 
superior outcomes with HIIT are resultant from briefer session durations provoking less cumulative 422 
training-induced RV wall stress. Since calculated cumulative work performed over the 6 weeks was 423 
comparable with HIIT and CExT, we believe that this alternative explanation is not as likely, and chose to 424 
keep HIIT session durations unmatched to facilitate translation of findings to a customary HIIT 425 
prescription for patients. In terms of time cost, the shorter training sessions of HIIT may provide 426 
additional appeal to patients as time constraints are commonly cited as barriers to exercise adherence (20). 427 
Not only may short bouts of higher intensity exercise may be more enjoyable than longer, steady state 428 
effort of continuous exercise (7), the anaerobic energy utilization required in HIIT may better mimic the 429 
physiological requirements of activities of daily living in those with cardiopulmonary disease (10).   430 
Perspectives and Significance.  Our report identifies for the first time that exercise training using a HIIT 431 
approach is superior to customary CExT for improving hemodynamics and RV remodeling and 432 
dysfunction in a rat model of PAH, and does not promote RV inflammation or cardiomyocyte apoptosis. 433 
These outcomes with HIIT may be explained by pulsatile pulmonary vascular exposure to flow-shear 434 
stimulus promoting pulmonary eNOS upregulation, coupled with reduced fibrosis, apelin upregulation, 435 
and improved metabolic profile in the RV muscle.  The pulmonary pressure- reducing and RV-preserving 436 
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effect observed only with HIIT encourages further investigation of this alternative training approach in 437 
other models and in patients as a potentially more optimal exercise regimen for PAH.   438 
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Figure legends 651 
Figure 1.  Study protocol. Following a period of treadmill familiarization, maximal oxygen uptake 652 
(VO2max) was measured. Rats then received either monocrotaline (MCT, 40 mg/kg, i.p.) to induce PAH 653 
(n=25), or saline, for healthy controls (n=17). Two weeks later, VO2max testing was repeated to establish 654 
pre-training values, and echocardiography was performed on a subset of rats. A 6-week treadmill program 655 
was then initiated for rats assigned to exercise training, performed in 5 sessions/week. CExT (n=12) 656 
performed 60 min of uninterrupted steady state running at 50% of VO2 Reserve (VO2R) determined in the 657 
second exercise test. HIIT (n=14) performed a brief warm up then five cycles of alternating high and low 658 
intensity intervals: 2 min at 85-90% VO2R and 3 min at 30% VO2R, totaling 30 min).  Rats assigned to 659 
remain sedentary (SED, n=16) were placed on a stationary treadmill on a matched schedule. At the 660 
conclusion of 6 weeks, final VO2max testing and echocardiography was performed, and three days later, 661 
invasive hemodynamic measures were performed, followed by sacrifice and tissue harvest.   662 
Figure 2.  Aerobic exercise capacity and body mass. A) For rats with monocrotaline (MCT, 40 mg/kg) 663 
induced PAH (black lines/symbols), decrement in VO2max (expressed relative to body mass) was 664 
ameliorated by both a high intensity interval training approach (HIIT, dashed line/triangles, n=8), and a 665 
continuous exercise training approach (CExT, dotted line/circles, n=7), vs. untrained MCT (SED, solid 666 
line/squares, n=10), with change after 6 wks of training (8 wk time point) compared to pre-training (2 wk 667 
time point) not different (p>0.05) from that in healthy HIIT, CExT, and SED control rats (CON, gray 668 
lines/symbols, n=5-6 ea). B) MCT-induced decrement in treadmill run time (time to VO2max) was also 669 
significantly improved by CExT and HIIT.  C) Body mass was significantly impacted by time for all 670 
groups, but not differently affected by group assignment. *p<0.05, **p<0.01 671 
Figure 3.  Pulmonary hypertension and exercise hemodynamics. A) For rats with monocrotaline (MCT, 672 
40 mg/kg) induced PAH (black bars), MCT-induced elevation in resting RV systolic pressure (RVSP) 673 
was attenuated by a high intensity interval training (HIIT, n=8) but not continuous exercise training 674 
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(CExT, n=7) approach, with RVSP of MCT-HIIT similar to that in healthy HIIT, CExT, and SED control 675 
rats (CON, gray bars, n=5-6 ea). *p<0.05; **p<0.01  B) Serial measures of simultaneous RV systolic and 676 
mean systemic resting pressures (BP) in an awake, freely-moving rat instrumented for implantable 677 
telemetry. Recordings are shown for pre-, and 2, 4, 6, 8, and 10 weeks post-MCT (40 mg/kg) injection.  678 
C) Real-time tracings of heart rate (HR, upper), and pulmonary (RVSP, lower) and systemic (mean BP, 679 
middle) pressures recorded via implantable telemetry are shown during HIIT running (left panel) and 680 
CExT running (right panel) for a rat at 4 wks post-MCT (40 mg/kg). Note the intermittent surges in RVSP 681 
that correspond to high (HI) and low (Lo) intensity intervals during HIIT which are absent during CExT. 682 
D) Change in RVSP relative to resting values during a session of CExT (solid gray), and during the high 683 
intensity (‘Hi’, solid black) and low intensity (‘Lo’ solid white) intervals of a HIIT session recorded in the 684 
instrumented rat at baseline (pre-MCT), and at 2, 4, 6, and 8 wks post-MCT. Change in RVSP from 685 
resting values during recovery from both CExT and HIIT run session are also indicated at each time point, 686 
as striped gray and black bars, respectively.  687 
 688 
Figure 4.  Lung eNOS expression and vascular remodeling. A) For rats with monocrotaline (MCT, 40 689 
mg/kg) induced PAH (black bars), only high intensity interval training (HIIT, n=8), and not continuous 690 
exercise training (CExT, n=7), significantly increased lung eNOS abundance vs. untrained animals (SED, 691 
n=10) as assessed by immunoblotting (expressed as fold difference from mean value for untreated 692 
controls (CON-SED, gray bar, n=6). A representative immunoblot showing the band corresponding to 693 
eNOS and to vinculin (loading control) is also shown. B) MCT-induced thickening of pulmonary arterial 694 
walls (PA wall thickness as fraction of vessel area) was not significantly different following either HIIT 695 
or CExT compared to SED, for either small diameter (<100 µm, left panel), or medium diameter (100-200 696 
µm, right panel) vessels in MCT; however PA wall thickness in both small and medium vessels was only 697 
significantly greater for untrained MCT (MCT-SED) when compared to untreated healthy controls (CON-698 
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SED).  Representative images of VVG-stained elastin surrounding arteries (arrows) in lung sections is 699 
also provided. *p<0.05; **p<0.01 700 
Figure 5.  RV hypertrophy and function. A) For rats with monocrotaline (MCT, 40 mg/kg) induced PAH 701 
(black bars), elevation in ratio of RV to LV+S mass (Fulton index, a measure of RV hypertrophy) was 702 
attenuated by a high intensity interval training (HIIT, n=8) but not continuous exercise training (CExT, 703 
n=7) approach, with values for MCT-HIIT significantly lower (p<0.01) than MCT-CExT and untrained 704 
(SED) MCT (n=10), and similar to that for healthy HIIT, CExT, and SED control rats (CON, gray bars, 705 
n=5-6 ea). Representative photographs show a top-down view of hearts (great vessels and atria removed) 706 
from MCT-CExT, MCT-HIIT, MCT-SED, and CON-SED where increased thickness of RV (far right 707 
wall) relative to LV (far left wall) for MCT-CExT and MCT-SED can be appreciated. B through D) 708 
Echocardiography performed pre- (‘2 wks’) and post- (‘8 wks’) intervention for HIIT (dashed 709 
line/triangles, n=8 MCT [black, upper panels], n=4 CON [gray, lower panels]) and SED (solid 710 
line/squares, n=8 MCT, n=4 CON) demonstrate that in HIIT trained MCT rats, increase in RV wall 711 
thickness (B) was ameliorated, and cardiac output (expressed normalized by body mass as cardiac index, 712 
C) was better maintained.  Calculated final total pulmonary vascular resistance index (TPRi, panel D) was 713 
also lower for MCT-HIIT vs MCT-SED. *p<0.05; **p<0.01 714 
Figure 6. RV and soleus metabolism. Abundance of glucose transporter Glut-1 was greater for RV (A) 715 
and soleus (C) in sedentary rats with monocrotaline (MCT, 40 mg/kg) induced PAH (black bars, MCT-716 
SED, n=10) vs. sedentary healthy controls (gray bars, CON-SED, n=6). In the RV (A), trained MCT had 717 
less Glut-1 compared to SED MCT whether they followed either a high intensity interval training (HIIT, 718 
n=8) or continuous exercise training (CExT, n=7) approach. Immunoblotting for oxidative 719 
phosphorylation proteins (OXPHOS) in RV homogenates (B) indicated that training also increased 720 
expression of electron transport chain cytochrome IV (expressed as fold difference from MCT-SED for 721 
loading control-normalized densitometry value), but only for rats trained with a HIIT approach.  For the 722 
soleus (C and D), a training effect toward attenuating MCT-induced dependence on glycolytic 723 
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metabolism was also observed, but opposite to the RV, only occurred for CExT and not HIIT. CExT-724 
trained MCT tended to express less Glut-1 (C) and more cytochrome III in OXPHOS immunoblots of 725 
soleus homogenates (D) compared to MCT-HIIT, with mean values not significantly different than that 726 
for CON-SED. Abundance of Glut-1 was measured by mean pixel intensity of red immunofluorescent 727 
staining shown in representative images, with green representing wheat-germ agglutin stained myocyte 728 
membrane and blue representing nuclei. A representative immunoblot showing the band corresponding to 729 
cytochrome III and to vinculin (loading control) is also shown. Results depicted in bar graphs to the left 730 
of images is expressed as fold difference from MCT-SED in mean pixel intensity. *p<0.05; **p<0.01 731 
Figure 7.  RV inflammation, apoptosis, fibrosis, and apelin expression.  A) Immunoblotting of RV 732 
homogenates for the anti-apoptotic/anti-inflammatory mediator and positive inotropic regulator apelin in 733 
rats with monocrotaline-induced (40 mg/kg) PAH (MCT, black bars) and untreated healthy control rats 734 
(CON, gray bars) revealed a higher protein abundance in MCT that were trained with high-intensity 735 
interval training (HIIT, n=8) but not with continuous exercise training (CExT, n=7). Values are expressed 736 
as fold difference from untrained (SED) MCT (n=8). In fixed RV sections of MCT rats (MCT, black bars) 737 
and untreated healthy control rats (CON, gray bars) infiltration of CD45+ cells (lymphocytes, B) 738 
measured by immunofluorescent staining (count per field, mean±SEM) was not different from untrained 739 
animals (SED), either after a HIIT or CExT approach. Adjacent panels are representative images with 740 
arrows indicating examples of CD45+ (red) cells, with green representing wheat-germ agglutin stained 741 
myocyte membrane and blue representing nuclei. Terminal deoxynucleotidyl transferase dUTP nick end 742 
labeling (TUNEL) staining for myocyte apoptosis was also performed (% of TUNEL+ cells, mean±SEM, 743 
C). Adjacent panels are representative images, including a positive and negative control slide, with arrows 744 
indicating examples of TUNEL+ (bright green) cells, and blue representing non-apoptotic nuclei. RV 745 
sections were additionally assessed for fibrosis with Masson’s trichrome (blue, in images) staining (D) 746 
and MCT-induced increase in RV fibrosis (expressed as fold difference from MCT-SED in % positively-747 
stained field) was less for HIIT-trained MCT. *p<0.05; **p<0.01 748 
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